Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of LEXX is 3.8 and suggests 396% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell